“Effect of Non-Nucleoside Resistance Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights from the Real-World RELATIVITY Cohort” (Open Forum Infectious Diseases, 2026)